1. Allyl isothiocyanate inhibits cell metastasis through suppression of the MAPK pathways in epidermal growth factor-stimulated HT29 human colorectal adenocarcinoma cells
   KUANG-CHI LAI et al, 2014 CrossRef
2. Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors
   Bálint Szokol et al, 2014, ACS Med. Chem. Lett. CrossRef
3. Phase 2 study of tivantinib and cetuximab in KRAS wild-type metastatic colorectal cancer patients with acquired resistance to EGFR inhibitors and emergence of MET overexpression: lesson learned for future trials with EGFR/MET dual inhibition
   Lorenza Rimassa et al, 2019, Clinical Colorectal Cancer CrossRef
4. Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma.
   Özlem Çoban et al, 2019, Drug Dev Res CrossRef
5. The potential therapeutic and prognostic impacts of the c‐MET/HGF signaling pathway in colorectal cancer
   Seyed Mostafa Parizadeh et al, 2019, IUBMB Life CrossRef
6. De NovoProteome Analysis of Genetically Modified Tumor Cells By a Metabolic Labeling/Azide-alkyne Cycloaddition Approach
   Seda Ballikaya et al, 2014, Mol Cell Proteomics CrossRef
7. Src is a novel potential off-target of RXR agonists, 9-cis-UAB30 and Targretin, in human breast cancer cells
   Mi-Sung Kim et al, 2015, Mol. Carcinog. CrossRef
8. Molecular Markers Predictive of Chemotherapy Response in Colorectal Cancer
   Stacey Shiovitz et al, 2015, Curr Gastroenterol Rep CrossRef
9. YKL-40/c-Met Expression in Rectal Cancer Biopsies Predicts Tumor Regression following Neoadjuvant Chemoradiotherapy: A Multi-Institutional Study
   Rebecca Senetta et al, 2015, PLoS ONE CrossRef
10. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer
    Bojiang Chen et al, 2015, J Exp Clin Cancer Res CrossRef
11. Quercetin metabolites inhibit MMP-2 expression in A549 lung cancer cells by PPAR-γ associated mechanisms
    Cheng-Hung Chuang et al, 2016, The Journal of Nutritional Biochemistry CrossRef
12. Recombinant Lactococcus lactis NZ9000 secretes a bioactive kisspeptin that inhibits proliferation and migration of human colon carcinoma HT-29 cells
    Bo Zhang et al, 2016, Microb Cell Fact CrossRef
13. Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic Ductal Adenocarcinoma
    Vijay Sagar Madamsetty et al, 2019, Bioconjugate Chem. CrossRef
14. Disruption of IGF‑1R signaling by a novel quinazoline derivative, HMJ‑30, inhibits invasiveness and reverses epithelial-mesenchymal transition in osteosarcoma U‑2 OS cells
    Yu-Jen Chiu et al, 2018, Int J Oncol CrossRef
15. Blocking c-MET/ERBB1 Axis Prevents Brain Metastasis in ERBB2+ Breast Cancer
    Shailendra K. Gautam et al, 2020, Cancers CrossRef
16. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer
    Ashraf N. Abdalla et al, 2021, Molecules CrossRef
17. A novel quinazoline derivative, MJ-56, exhibits phototoxicity toward human bladder cancer cells
    Hung-En Chen et al, 2018, Urol Sci CrossRef
18. Selective and Nongenetic Peroxidase Tag of Membrane Protein: a Nucleic Acid Tool for Proximity Labeling
    Wen Yang et al, 2021, Anal. Chem. CrossRef
19. Colorectal liver metastasis: molecular mechanism and interventional therapy.
    Hui Zhou et al, 2022, Signal Transduct Target Ther CrossRef
20. Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy
    Lun Tan et al, 2022, J. Med. Chem. CrossRef
21. Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review
    Chao Wang et al, 2023, International Journal of Biological Macromolecules CrossRef
22. Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
    Sheng Tang et al, 2024, European Journal of Medicinal Chemistry CrossRef
23. Elaiophylin targets EIF4B to suppress the growth of esophageal squamous cell carcinoma via the PI3K/AKT signaling pathway
    Hu Qiu et al, 2024, Cancer Letters CrossRef